It’s time to finally kill the zombies comment on “universal pharmacare in canada”

1Citations
Citations of this article
12Readers
Mendeley users who have this article in their library.

Abstract

The movement for a national pharmacare plan in Canada is growing, but at the same time the multinational pharmaceutical companies and their supporters are critical of such a move. The three major arguments that they make are that all that is needed is to “fill in the gaps,” ie, cover those who currently are uninsured or underinsured, that private drug plans are superior to public ones because they cover a larger number of drugs and that Canada cannot afford pharmacare. This commentary examines each of these arguments and makes the case that none of them is valid and that it is time to get on with implementing pharmacare.

Cite

CITATION STYLE

APA

Lexchin, J. (2020, December 1). It’s time to finally kill the zombies comment on “universal pharmacare in canada.” International Journal of Health Policy and Management. Kerman University of Medical Sciences. https://doi.org/10.15171/ijhpm.2020.03

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free